Human papillomavirus and cervical carcinogenesis: Viral mechanism, risk factors, and prevention
Keywords:
Cancer, human papillomavirus (HPV), HPV vaccination, lesions, mucosal epitheliumAbstract
The incidence of Human Papillomavirus (HPV) infection is one of the frequently viral infections known worldwide. HPV primarily infects the basal epithelial cells of the cervix, although many types can also infect cutaneous epithelium. Through the method of genetic sequencing there are greater than 200 distinct types that have been recognized. Among them, 40 types can affect mucosal epithelium and induce cellular proliferation. A subset of these mucosal types is "high-risk" and is associated with cellular proliferation leading to cancer. whereas the "low-risk" types typically cause benign lesions. They are primarily transmitted through sexual contacts involving skin-toskin contact. Mother to child transmission during childbirth is rare. The maximum number of the HPV infections are short lived and are evacuated with 50% resolving within six months by the immune system, and 90% becoming undetectable within one to two years. The risk factor that occurs primarily for the development of cervical cancer is considered to be viral infection only to be resolved with treatment or strong immunological response. Cancer from HPV infection is curable if detected early however it is crucial to take preventive precautions such as safe sexual practices and HPV vaccination. The rate of HPV- related infections and precancerous lesions in many populations is reduced significantly by the vaccine of Human Papillomavirus (HPV). The review summarizes that the function of Human Papillomavirus (HPV) in cervical carcinogenesis that also include viral mechanisms, risk factors, and preventive strategies of the respective virus.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.



